不良事件报告系统
精神病
数据库
不利影响
医学
计算机科学
药理学
精神科
作者
Jun Gu,Yucai Qu,Yüan Shen,Qin Zhou,Ying Jiang,Haohao Zhu
标识
DOI：10.1016/j.jad.2024.07.103
摘要
Pimavanserin, a novel 5-HT2A receptor antagonist, has been approved for the treatment of Parkinson's disease psychosis (PDP). This study aims to conduct a comprehensive analysis of the adverse events (AEs) of pimavanserin by analyzing the FDA's Adverse Event Reporting System (FAERS) database.
科研通智能强力驱动
Strongly Powered by AbleSci AI
爱静静
Singularity
HEIKU
Hayat
shinysparrow
不配.
云瑾
curtisness
Henry
kento
zzzyyy
rosalieshi
一一
浅尝离白
元谷雪
徐叽钰
zyfqpc
琉璃苣
8R60d8
我不是BOB
皖公网安备34019202002308
